跳至主要内容
临床试验/NCT02772237
NCT02772237Unknown2 期

The Impact of Riboflavin on Sports-related Concussion: A Randomized Control Trial

University of Virginia2 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2016年8月最近更新:
适应症
干预措施

试验速览

阶段
2 期
入组人数
500
试验地点
2
主要终点
Time to return to participation in sports after a sports-related concussion

研究概览

简要总结

The purpose of this study is to investigate the effectiveness of riboflavin to decrease the duration of time for a student-athlete to return to participation in sports after a sports related concussion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All UVa and JMU student-athletes over the age of 18 years old who are diagnosed with a sports related concussion

排除标准

  • Less than 18 years old
  • Greater than 24 hours have elapsed since the concussion occurred.
  • The student-athlete has already participated in the study during which he/she took Riboflavin
  • Non-sports related concussion not incurred while participating in the sport or training for the sport. As an example, a student-athlete who sustains a concussion as a result of a motor vehicle accident will be excluded from the study for that concussion.
  • A previous concussion within the last 12 months.
  • Any concussion that is complicated by a cranial bleed, skull fracture, additional severe injury (e.g. torn knee ligament) that might affect the return to normal activities above and beyond the sport-related concussion.
  • If the student athlete is cognitively impaired to a level that prevents verbal communication, the consent will be deemed 'opted out' and the student-athlete will not be enrolled in the study.

研究组 & 干预措施

Placebo group

Placebo Comparator

Placebo

干预措施: Placebo (Biological)

Treatment group

Active Comparator

Riboflavin 400mg daily

干预措施: Riboflavin (Biological)

结局指标

主要结局

Time to return to participation in sports after a sports-related concussion

时间窗: 14 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeremy Kent, MD

Assistant Professor

University of Virginia

研究点 (2)

Loading locations...

相似试验